Spectrum Pharma (SPPI) Tops Q4 EPS by 17c
Get Alerts SPPI Hot Sheet
Join SI Premium – FREE
Spectrum Pharma (NASDAQ: SPPI) reported Q4 EPS of ($0.10), $0.17 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $32.2 million versus the consensus estimate of $31.13 million.
For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Red River Bancshares, Inc. (RRBI) Tops Q3 EPS by 7c
- Verra Mobility (VRRM) Tops Q3 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share